nach oben

Acta Diabetologica

Erschienen in:

29.06.2017 | Review Article

Epicardial adipose tissue: at the heart of the obesity complications

verfasst von: Valeria Guglielmi, Paolo Sbraccia

Erschienen in: Acta Diabetologica | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

In recent years, the anatomic and functional contiguity of epicardial adipose tissue (EAT) to myocardium and coronary arteries has gained increasing interest for its potential pathogenetic role in obesity-related cardiac diseases. Besides its known and attributed biochemical cardioprotective properties, it is becoming evident that, in metabolic disease states, EAT-secreted bioactive molecules may play an important role in the pathogenesis of coronary artery disease and cardiac arrhythmias. EAT-derived inflammatory cytokines and reactive oxidative species may, indeed, play a part in the development of a local proatherogenic milieu by paracrine and vasocrine mechanisms of interaction. In addition, initial clinical and in vitro studies have pointed out that EAT could be a determinant of the substrate of atrial fibrillation by contributing to the structural and electrical remodeling of myocardium. This article reviews the current state of knowledge on the association of EAT with cardiac dysfunction and the potential factors mediating the cross talk between this fat depot and the underlying cardiac structures.

Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772–783. doi:10.1038/nri1937 CrossRefPubMed

Coelho M, Oliveira T, Fernandes R (2013) Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 9(2):191–200. doi:10.5114/aoms.2013.3318120246 CrossRefPubMedPubMedCentral

Guglielmi V, D’Adamo M, Bellia A et al (2015) Iron status in obesity: an independent association with metabolic parameters and effect of weight loss. Nutr Metab Cardiovasc Dis 25(6):541–547. doi:10.1016/j.numecd.2015.02.012S0939-4753(15)00055-1 CrossRefPubMed

Marucci A, Menzaghi C, Copetti M et al (2015) Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity. Acta Diabetol 52(5):991–998. doi:10.1007/s00592-015-0804-2 CrossRefPubMed

Coutinho T, Goel K, Correa de Sa D et al (2011) Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 57(19):1877–1886. doi:10.1016/j.jacc.2010.11.058S0735-1097(11)00732-7 CrossRefPubMed

Lombardi F, Gullotta F, Columbaro M et al (2007) Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype. J Clin Endocrinol Metab 92(11):4467–4471. doi:10.1210/jc.2007-0116 CrossRefPubMed

Guglielmi V, D’Adamo M, D’Apice MR et al (2010) Elbow deformities in a patient with mandibuloacral dysplasia type A. Am J Med Genet A 152A(11):2711–2713. doi:10.1002/ajmg.a.33700 CrossRefPubMed

Guglielmi V, Maresca L, D’Adamo M et al (2014) Age-related different relationships between ectopic adipose tissues and measures of central obesity in sedentary subjects. PLoS ONE 9(7):e103381. doi:10.1371/journal.pone.0103381PONE-D-14-22290 CrossRefPubMedPubMedCentral

Sacks HS, Fain JN (2007) Human epicardial adipose tissue: a review. Am Heart J 153(6):907–917. doi:10.1016/j.ahj.2007.03.019 CrossRefPubMed

10.

Kwok KH, Lam KS, Xu A (2016) Heterogeneity of white adipose tissue: molecular basis and clinical implications. Exp Mol Med 48:e215. doi:10.1038/emm.2016.5emm20165 CrossRefPubMedPubMedCentral

11.

Morano S, Romagnoli E, Filardi T et al (2015) Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study. Acta Diabetol 52(4):727–732. doi:10.1007/s00592-014-0710-z CrossRefPubMed

12.

Iozzo P (2011) Myocardial, perivascular, and epicardial fat. Diabetes Care 34(Suppl 2):S371–S379. doi:10.2337/dc11-s25034/Supplement_2/S371 CrossRefPubMedPubMedCentral

13.

Bertaso AG, Bertol D, Duncan BB, Foppa M (2013) Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 101(1):e18–e28. doi:10.5935/abc.20130138S0066-782X2013002700020 PubMedPubMedCentral

14.

Iacobellis G (2009) Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring) 17(4):625. doi:10.1038/oby.2008.575oby2008575 (author reply 626–627) CrossRef

15.

Iacobellis G, Willens HJ (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22(12):1311–1319. doi:10.1016/j.echo.2009.10.013S0894-7317(09)00996-1 (quiz 1417-1318) CrossRefPubMed

16.

Gorter PM, van Lindert AS, de Vos AM et al (2008) Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 197(2):896–903. doi:10.1016/j.atherosclerosis.2007.08.016 CrossRefPubMed

17.

Schejbal V (1989) Epicardial fatty tissue of the right ventricle–morphology, morphometry and functional significance. Pneumologie 43(9):490–499PubMed

18.

Ouwens DM, Sell H, Greulich S, Eckel J (2010) The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 14(9):2223–2234. doi:10.1111/j.1582-4934.2010.01141.xJCMM1141 CrossRefPubMedPubMedCentral

19.

Marchington JM, Pond CM (1990) Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 14(12):1013–1022PubMed

20.

Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan AK, Cheema PS (2010) Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism 59(9):1379–1386. doi:10.1016/j.metabol.2009.12.027S0026-0495(09)00546-0 CrossRefPubMed

21.

Sacks HS, Fain JN (2011) Human epicardial fat: what is new and what is missing? Clin Exp Pharmacol Physiol 38(12):879–887. doi:10.1111/j.1440-1681.2011.05601.x CrossRefPubMed

22.

Chechi K, Blanchard PG, Mathieu P, Deshaies Y, Richard D (2013) Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int J Cardiol 167(5):2264–2270. doi:10.1016/j.ijcard.2012.06.008S0167-5273(12)00783-8 CrossRefPubMed

23.

Sacks HS, Fain JN, Bahouth SW et al (2013) Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab 98(9):E1448–E1455. doi:10.1210/jc.2013-1265jc.2013-1265 CrossRefPubMed

24.

Vijgen GH, Bouvy ND, Teule GJ et al (2012) Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 97(7):E1229–E1233. doi:10.1210/jc.2012-1289jc.2012-1289 CrossRefPubMed

25.

Iacobellis G, di Gioia CR, Di Vito M et al (2009) Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 41(12):855–860. doi:10.1055/s-0029-1231081 CrossRefPubMed

26.

Iacobellis G, di Gioia CR, Cotesta D et al (2009) Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res 41(3):227–231. doi:10.1055/s-0028-1100412 CrossRefPubMed

27.

Fain JN, Sacks HS, Buehrer B et al (2008) Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond) 32(5):810–815. doi:10.1038/sj.ijo.08037900803790 CrossRef

28.

Cikim AS, Topal E, Harputluoglu M et al (2007) Epicardial adipose tissue, hepatic steatosis and obesity. J Endocrinol Invest 30(6):459–464. doi:10.1007/BF03346328 CrossRefPubMed

29.

Iacobellis G, Ribaudo MC, Assael F et al (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88(11):5163–5168. doi:10.1210/jc.2003-030698 CrossRefPubMed

30.

Iacobellis G, Barbaro G, Gerstein HC (2008) Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 128(3):424–426. doi:10.1016/j.ijcard.2007.12.072S0167-5273(08)00127-7 CrossRefPubMed

31.

Wang CP, Hsu HL, Hung WC et al (2009) Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) 70(6):876–882. doi:10.1111/j.1365-2265.2008.03411.xCEN3411 CrossRef

32.

Iacobellis G, Willens HJ, Barbaro G, Sharma AM (2008) Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16(4):887–892. doi:10.1038/oby.2008.6oby20086 CrossRef

33.

Rabkin SW (2014) The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord 12(1):31–42. doi:10.1089/met.2013.0107 CrossRefPubMed

34.

Malavazos AE, Di Leo G, Secchi F et al (2010) Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 105(12):1831–1835. doi:10.1016/j.amjcard.2010.01.368S0002-9149(10)00527-8 CrossRefPubMed

35.

Mahabadi AA, Massaro JM, Rosito GA et al (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30(7):850–856. doi:10.1093/eurheartj/ehn573ehn573 CrossRefPubMedPubMedCentral

36.

Bettencourt N, Toschke AM, Leite D et al (2012) Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol 158(1):26–32. doi:10.1016/j.ijcard.2010.12.085S0167-5273(10)01145-9 CrossRefPubMed

37.

Iwayama T, Nitobe J, Watanabe T et al (2014) Role of epicardial adipose tissue in coronary artery disease in non-obese patients. J Cardiol 63(5):344–349. doi:10.1016/j.jjcc.2013.10.002S0914-5087(13)00301-8 CrossRefPubMed

38.

Strissel KJ, Denis GV, Nikolajczyk BS (2014) Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease. Curr Opin Endocrinol Diabetes Obes 21(5):330–338. doi:10.1097/MED.0000000000000085 CrossRefPubMedPubMedCentral

39.

Greif M, Becker A, von Ziegler F et al (2009) Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 29(5):781–786. doi:10.1161/ATVBAHA.108.180653ATVBAHA.108.180653 CrossRefPubMed

40.

McKenney ML, Schultz KA, Boyd JH et al (2014) Epicardial adipose excision slows the progression of porcine coronary atherosclerosis. J Cardiothorac Surg 9:2. doi:10.1186/1749-8090-9-21749-8090-9-2 CrossRefPubMedPubMedCentral

41.

Mazurek T, Zhang L, Zalewski A et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466. doi:10.1161/01.CIR.0000099542.57313.C501.CIR.0000099542.57313.C5 CrossRefPubMed

42.

Baker AR, Harte AL, Howell N et al (2009) Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 94(1):261–267. doi:10.1210/jc.2007-2579jc.2007-2579 CrossRefPubMed

43.

Pedicino D, Severino A, Ucci S et al (2017) Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome. Int J Cardiol 236:95–99. doi:10.1016/j.ijcard.2017.02.040 CrossRefPubMed

44.

Karastergiou K, Fried SK (2013) Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr Atheroscler Rep 15(10):361. doi:10.1007/s11883-013-0361-5 CrossRefPubMedPubMedCentral

45.

Henrichot E, Juge-Aubry CE, Pernin A et al (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25(12):2594–2599. doi:10.1161/01.ATV.0000188508.40052.35 CrossRefPubMed

46.

Salgado-Somoza A, Teijeira-Fernandez E, Rubio J, Couso E, Gonzalez-Juanatey JR, Eiras S (2012) Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf) 76(1):51–58. doi:10.1111/j.1365-2265.2011.04140.x CrossRef

47.

Dozio E, Vianello E, Briganti S et al (2014) Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation. Int J Cardiol 174(2):413–414. doi:10.1016/j.ijcard.2014.04.045S0167-5273(14)00704-9 CrossRefPubMed

48.

Ahmadi N, Nabavi V, Hajsadeghi F et al (2013) Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis. Int J Cardiol 168(3):2310–2314. doi:10.1016/j.ijcard.2013.01.182S0167-5273(13)00242-8 CrossRefPubMed

49.

Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22(11):450–457. doi:10.1016/j.tem.2011.07.003S1043-2760(11)00112-3 CrossRefPubMedPubMedCentral

50.

Hatem SN, Redheuil A, Gandjbakhch E (2016) Cardiac adipose tissue and atrial fibrillation: the perils of adiposity. Cardiovasc Res 109(4):502–509. doi:10.1093/cvr/cvw001cvw001 CrossRefPubMed

51.

Guglielmi V, Maresca L, Lanzillo C et al (2016) Relationship between regional fat distribution and hypertrophic cardiomyopathy phenotype. PLoS ONE 11(7):e0158892. doi:10.1371/journal.pone.0158892PONE-D-16-00255 CrossRefPubMedPubMedCentral

52.

Tsao HM, Hu WC, Wu MH et al (2011) Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am J Cardiol 107(10):1498–1503. doi:10.1016/j.amjcard.2011.01.027S0002-9149(11)00339-0 CrossRefPubMed

53.

Nagashima K, Okumura Y, Watanabe I et al (2011) Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation. Circ J 75(11):2559–2565. doi:10.1253/circj.CJ-11-0554 CrossRefPubMed

54.

Muhib S, Fujino T, Sato N, Hasebe N (2013) Epicardial adipose tissue is associated with prevalent atrial fibrillation in patients with hypertrophic cardiomyopathy. Int Heart J 54(5):297–303. doi:10.1536/ihj.54.297 CrossRefPubMed

55.

Opolski MP, Staruch AD, Kusmierczyk M et al (2015) Computed tomography angiography for prediction of atrial fibrillation after coronary artery bypass grafting: proof of concept. J Cardiol 65(4):285–292. doi:10.1016/j.jjcc.2014.12.006S0914-5087(14)00359-1 CrossRefPubMed

56.

Guglielmi V, Cardellini M, Cinti F et al (2015) Omental adipose tissue fibrosis and insulin resistance in severe obesity. Nutr Diabetes 5:e175. doi:10.1038/nutd.2015.22nutd201522 CrossRefPubMedPubMedCentral

57.

Cancello R, Tordjman J, Poitou C et al (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55(6):1554–1561. doi:10.2337/db06-0133 CrossRefPubMed

58.

Jiang DS, Zeng HL, Li R et al (2017) Aberrant epicardial adipose tissue extracellular matrix remodeling in patients with severe ischemic cardiomyopathy: insight from comparative quantitative proteomics. Sci Rep 7:43787. doi:10.1038/srep43787srep43787 CrossRefPubMedPubMedCentral

59.

Venteclef N, Guglielmi V, Balse E et al (2015) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 36(13):795–805a. doi:10.1093/eurheartj/eht099eht099 CrossRefPubMed

60.

Greulich S, Maxhera B, Vandenplas G et al (2012) Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation 126(19):2324–2334. doi:10.1161/CIRCULATIONAHA.111.039586CIRCULATIONAHA.111.039586 CrossRefPubMed

61.

Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P (2016) Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm 13(1):311–320. doi:10.1016/j.hrthm.2015.08.016S1547-5271(15)01030-9 CrossRefPubMed

62.

Nakanishi K, Fukuda S, Tanaka A et al (2012) Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation. Circ J 76(12):2748–2754. doi:10.1253/circj.CJ-12-0637 CrossRefPubMed

63.

Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 17(2):115–130. doi:10.5551/jat.1735 CrossRefPubMed

64.

Gaborit B, Venteclef N, Ancel P et al (2015) Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res 108(1):62–73. doi:10.1093/cvr/cvv208cvv208 CrossRefPubMed

65.

Sacks FM, Bray GA, Carey VJ et al (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360(9):859–873. doi:10.1056/NEJMoa0804748360/9/859 CrossRefPubMedPubMedCentral

66.

Lombardo M, Bellia A, Padua E et al (2014) Morning meal more efficient for fat loss in a 3-month lifestyle intervention. J Am Coll Nutr 33(3):198–205. doi:10.1080/07315724.2013.863169 CrossRefPubMed

67.

Bellia A, Salli M, Lombardo M et al (2014) Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects. Int J Sports Med 35(6):511–516. doi:10.1055/s-0033-1354358 PubMed

68.

Jakicic JM, Otto AD (2005) Physical activity considerations for the treatment and prevention of obesity. Am J Clin Nutr 82(1 Suppl):226S–229SPubMed

69.

Lombardo M, Bellia A, Mattiuzzo F et al (2015) Frequent follow-up visits reduce weight regain in long-term management after bariatric surgery. Bariatr Surg Pract Patient Care 10(3):119–125. doi:10.1089/bari.2015.0021 CrossRef

70.

Frikke-Schmidt H, O’Rourke RW, Lumeng CN, Sandoval DA, Seeley RJ (2016) Does bariatric surgery improve adipose tissue function? Obes Rev 17(9):795–809. doi:10.1111/obr.12429 CrossRefPubMedPubMedCentral

71.

Hansen M, Lund MT, Jorgensen AL et al (2016) The effects of diet- and RYGB-induced weight loss on insulin sensitivity in obese patients with and without type 2 diabetes. Acta Diabetol 53(3):423–432. doi:10.1007/s00592-015-0812-210.1007/s00592-015-0812-2 CrossRefPubMed

72.

Rabkin SW, Campbell H (2015) Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev 16(5):406–415. doi:10.1111/obr.12270 CrossRefPubMed

73.

Park JH, Park YS, Kim YJ et al (2010) Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound 18(4):121–126. doi:10.4250/jcu.2010.18.4.121 CrossRefPubMedPubMedCentral

74.

Jonker JT, Lamb HJ, van der Meer RW et al (2010) Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(1):456–460. doi:10.1210/jc.2009-1441jc.2009-1441 CrossRefPubMed

Titel: Epicardial adipose tissue: at the heart of the obesity complications
verfasst von: Valeria Guglielmi
Paolo Sbraccia
Publikationsdatum: 29.06.2017
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 9/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-017-1020-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Epicardial adipose tissue: at the heart of the obesity complications

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies

The honeymoon period repeatedly appears in two cases of type 1 diabetes mellitus

Team management of gestational diabetes: a training experience

Improving diabetes care at primary care level with a multistrategic approach: results of the DIAPREM programme

The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review

GLIS3 rs7020673 and rs10758593 polymorphisms interact in the susceptibility for type 1 diabetes mellitus

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin